C Brixko
12 Papers
15 Citations
C Brixko is an academic researcher. The author has contributed to research in topics: Medicine & Population. The author has an hindex of 4, co-authored 8 publications.
Chat about Author
Papers
Eliminating viral hepatitis C in Belgium: the micro-elimination approach.
Dana Busschots,Samira Toghanian,Rob Bielen,Stina Salomonsson,Ozguer M. Koc,Greet Hendrickx,Michel Jadoul,Frederik Nevens,Etienne Sokal,C Brixko,Kathelijne Peerlinck,Ludwig Apers,Geert Robaeys,Geert Robaeys,Jeffrey V. Lazarus +14 more
TL;DR: Removing Belgian treatment reimbursement restrictions in January 2019 was a big step towards eliminating HCV and increasing surveillance, including with a national registry, treatment prescription by other health-care providers and availability of treatment in local pharmacies are central to improving the current situation and getting on track to reach the 2030 WHO hepatitis C elimination targets in Belgium.
•Journal Article
Mitigating the burden of hepatitis C virus among people who inject drugs in Belgium
Catharina Matheï,Suzanne Bourgeois,Sarah Blach,C Brixko,Jean-Pierre Mulkay,Homie Razavi,Geert Robaeys +6 more
TL;DR: Treating a small number of PWID can result in substantial reduction in HCV prevalence in this population ; however, high levels of treatment are necessary to reduce the viral pool and thus the risk of secondary infections.
12
The risk of early occurrence and recurrence of hepatocellular carcinoma in hepatitis C infected patients treated with direct acting antivirals with and without pegylated interferon: a Belgian experience
Rob Bielen,Christophe Moreno,H. Van Vlierberghe,Suzanne Bourgeois,Jean-Pierre Mulkay,Sven Francque,Wim Verlinden,C Brixko,J Decaestecker,C de Galocsy,F Janssens,Mike Cool,C. Van Steenkiste,F D'Heygere,K. Wuyckens,Frederik Nevens,Geert Robaeys +16 more
9
Real-world effectiveness of sofosbuvir/velpatasvir for the treatment of hepatitis C virus in prison settings
Silvia Rosati,Alexander Wong,E. Di Marco,Paco Pérez-Hernandez,Guilherme Macedo,C Brixko,Roberto Ranieri,Francesca Campanale,Annalisa Basciá,Conrado M. Fernández-Rodríguez,Victor de Ledinghen,Ivana Maida,Elisabetta Teti,Alessandra Mangia,Kim Vanstraelen,Candido Hernandez,Michael Mertens,Ioanna Ntalla,Heribert Ramroth,Elena Jimenez +19 more
TL;DR: SOF/VEL for 12-weeks for 12 weeks is highly successful in prison settings and enables the implementation of a simple treatment algorithm in line with guideline recommendations and test-and-treat strategies.
5
The modeled impact of improved Hepatitis C Virus (HCV) treatment strategies on HCV prevalence among people who inject drugs (PWIDs) in Belgium
Catharina Matheï,Suzanne Bourgeois,C Brixko,Sarah Blach,Jean-Pierre Mulkay,Homie Razavi,Thomas Sersté,G. Robaeys +7 more
- 01 Jan 2015
TL;DR: [Mathei, Catharina] Katholieke Univ Leuvent, Univ Hosp Leuven, Dept Publ Hlth & Primary Care, Leuens, Belgium.
2